Author

N. Fares

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Morin mitigates doxorubicin-induced cardiotoxicity via suppression of oxidative stress, inflammation, and structural remodeling.

The clinical use of the anticancer drug doxorubicin is restricted by its ability to cause cardiotoxicity, often progressing to heart failure. Current cardiovascular treatments fail to restore cardiac function or improve long-term survival rates, demanding alternative therapeutic approaches to minimize the cardiotoxicit...

S. Elsayed, N. Fares, S. Elsharkawy et al. · Toxicology and Applied Pharm... · 0 citations

Open access Aug 2026

SULFORAPHANE SUPPRESSES HEPATOCELLULAR CARCINOMA IN MICE VIA ACTIVATING p53, MITIGATING OXIDATIVE STRESS, AND INHIBITING ANGIOGENESIS.

SF decreased the number of tumor nodules and ameliorated HCC by activating p53 expression, inducing apoptosis, and inhibiting proliferation, oxidative stress, and angiogenesis, and support further translational evaluation of SF as a potential therapeutic agent for HCC.

Kholoud A. Omran, Yomna I. Mahmoud, A. Mahmoud et al. · Experimental oncology · 0 citations